A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription

Cancer Cell

Volumn 17, Issue 2, 2010, Pages 198-212

  Yokoyama, Akihiko ^a   Lin, Min ^b   Naresh, Alpana ^b   Kitabayashi, Issay ^a   Cleary, Michael L ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLCYCLE; DNA

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; CYTOPLASM PROTEIN; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; ONCOPROTEIN; PROTEIN AF4; PROTEIN ENL; PROTEIN MLL AF6; PROTEIN P TEFB; TRANSCRIPTION ELONGATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSFORMATION; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY;

EID: 76349118080     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.12.040     Document Type: Article

References (58)

1. Ayton P.M., and Cleary M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17 (2003) 2298-2307
2. Ayton P.M., Chen E.H., and Cleary M.L. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell. Biol. 24 (2004) 10470-10478
3. Bitoun E., Oliver P.L., and Davies K.E. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum. Mol. Genet. 16 (2007) 92-106
4. Cheung N., Chan L.C., Thompson A., Cleary M.L., and So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nat. Cell Biol. 9 (2007) 1208-1215
5. Collins E.C., Appert A., Ariza-McNaughton L., Pannell R., Yamada Y., and Rabbitts T.H. Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia. Mol. Cell. Biol. 22 (2002) 7313-7324
6. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., and Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17 (2003) 3029-3035
7. Daser A., and Rabbitts T.H. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18 (2004) 965-974
8. DiMartino J.F., Miller T., Ayton P.M., Landewe T., Hess J.L., Cleary M.L., and Shilatifard A. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96 (2000) 3887-3893
9. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., and Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99 (2002) 3780-3785
10. Domer P.H., Fakharzadeh S.S., Chen C.S., Jockel J., Johansen L., Silverman G.A., Kersey J.H., and Korsmeyer S.J. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl. Acad. Sci. USA 90 (1993) 7884-7888
11. Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D., and Bohlander S.K. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc. Natl. Acad. Sci. USA 93 (1996) 4804-4809
12. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., and Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72 (1998) 8463-8471
13. Erfurth F., Hemenway C.S., de Erkenez A.C., and Domer P.H. MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia 18 (2004) 92-102
14. Gilliland D.G. Molecular genetics of human leukemias: new insights into therapy. Semin. Hematol. 39 (2002) 6-11
15. Guenther M.G., Jenner R.G., Chevalier B., Nakamura T., Croce C.M., Canaani E., and Young R.A. Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl. Acad. Sci. USA 102 (2005) 8603-8608
16. Guenther M.G., Lawton L.N., Rozovskaia T., Frampton G.M., Levine S.S., Volkert T.L., Croce C.M., Nakamura T., Canaani E., and Young R.A. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 22 (2008) 3403-3408
17. Hughes C.M., Rozenblatt-Rosen O., Milne T.A., Copeland T.D., Levine S.S., Lee J.C., Hayes D.N., Shanmugam K.S., Bhattacharjee A., Biondi C.A., et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13 (2004) 587-597
18. Huret J.L., Dessen P., and Bernheim A. An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners. Leukemia 15 (2001) 987-989
19. Iida S., Seto M., Yamamoto K., Komatsu H., Tojo A., Asano S., Kamada N., Ariyoshi Y., Takahashi T., and Ueda R. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 8 (1993) 3085-3092
20. Jansen M.W., van der Velden V.H., and van Dongen J.J. Efficient and easy detection of MLL-AF4, MLL-AF9 and MLL-ENL fusion gene transcripts by multiplex real-time quantitative RT-PCR in TaqMan and LightCycler. Leukemia 19 (2005) 2016-2018
21. Jones B., Su H., Bhat A., Lei H., Bajko J., Hevi S., Baltus G.A., Kadam S., Zhai H., Valdez R., et al. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet. 4 (2008) e1000190 10.1371/journal.pgen.1000190
22. Krivtsov A.V., and Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7 (2007) 823-833
23. Krivtsov A.V., Feng Z., Lemieux M.E., Faber J., Vempati S., Sinha A.U., Xia X., Jesneck J., Bracken A.P., Silverman L.B., et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14 (2008) 355-368
24. Lavau C., Szilvassy S.J., Slany R., and Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16 (1997) 4226-4237
25. Lavau C., Du C., Thirman M., and Zeleznik-Le N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 19 (2000) 4655-4664
26. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 (2007) 707-719
27. Ma C., and Staudt L.M. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. Blood 87 (1996) 734-745
28. McGinty R.K., Kim J., Chatterjee C., Roeder R.G., and Muir T.W. Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 453 (2008) 812-816
29. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., and Hess J.L. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10 (2002) 1107-1117
30. Milne T.A., Hughes C.M., Lloyd R., Yang Z., Rozenblatt-Rosen O., Dou Y., Schnepp R.W., Krankel C., Livolsi V.A., Gibbs D., et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. USA 102 (2005) 749-754
31. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 (2000) 1063-1066
32. Morrissey J.J., Raney S., and Cleary M.L. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations. Leuk. Res. 21 (1997) 911-917
33. Mueller D., Bach C., Zeisig D., Garcia-Cuellar M.P., Monroe S., Sreekumar A., Zhou R., Nesvizhskii A., Chinnaiyan A., Hess J.L., and Slany R.K. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110 (2007) 4445-4454
34. Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N., Gale R.P., Lange B., Crist W.M., Nowell P.C., et al. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. USA 90 (1993) 4631-4635
35. Nakamura T., Largaespada D.A., Shaughnessy Jr. J.D., Jenkins N.A., and Copeland N.G. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat. Genet. 12 (1996) 149-153
36. Nilson I., Reichel M., Ennas M.G., Greim R., Knorr C., Siegler G., Greil J., Fey G.H., and Marschalek R. Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br. J. Haematol. 98 (1997) 157-169
37. Okada Y., Feng Q., Lin Y., Jiang Q., Li Y., Coffield V.M., Su L., Xu G., and Zhang Y. hDOT1L links histone methylation to leukemogenesis. Cell 121 (2005) 167-178
38. Peterlin B.M., and Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23 (2006) 297-305
39. Prasad R., Yano T., Sorio C., Nakamura T., Rallapalli R., Gu Y., Leshkowitz D., Croce C.M., and Canaani E. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl. Acad. Sci. USA 92 (1995) 12160-12164
40. Pui C.H., Relling M.V., and Downing J.R. Acute lymphoblastic leukemia. N. Engl. J. Med. 350 (2004) 1535-1548
41. Saunders A., Core L.J., and Lis J.T. Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7 (2006) 557-567
42. Slany R.K., Lavau C., and Cleary M.L. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol. Cell. Biol. 18 (1998) 122-129
43. So C.W., and Cleary M.L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell. Biol. 22 (2002) 6542-6552
44. So C.W., and Cleary M.L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101 (2003) 633-639
45. Somervaille T.C., and Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10 (2006) 257-268
46. Srinivasan R.S., Nesbit J.B., Marrero L., Erfurth F., LaRussa V.F., and Hemenway C.S. The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells. Leukemia 18 (2004) 1364-1372
47. Steger D.J., Lefterova M.I., Ying L., Stonestrom A.J., Schupp M., Zhuo D., Vakoc A.L., Kim J.E., Chen J., Lazar M.A., et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell. Biol. 28 (2008) 2825-2839
48. Taki T., Kano H., Taniwaki M., Sako M., Yanagisawa M., and Hayashi Y. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl. Acad. Sci. USA 96 (1999) 14535-14540
49. Tkachuk D.C., Kohler S., and Cleary M.L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71 (1992) 691-700
50. von Bergh A.R., Beverloo H.B., Rombout P., van Wering E.R., van Weel M.H., Beverstock G.C., Kluin P.M., Slater R.M., and Schuuring E. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer 35 (2002) 92-96
51. Weinmann A.S., and Farnham P.J. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26 (2002) 37-47
52. Wong P., Iwasaki M., Somervaille T.C., So C.W., and Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21 (2007) 2762-2774
53. Yokoyama A., and Cleary M.L. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14 (2008) 36-46
54. Yokoyama A., Kitabayashi I., Ayton P.M., Cleary M.L., and Ohki M. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100 (2002) 3710-3718
55. Yokoyama A., Wang Z., Wysocka J., Sanyal M., Aufiero D.J., Kitabayashi I., Herr W., and Cleary M.L. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24 (2004) 5639-5649
56. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., and Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 (2005) 207-218
57. Zeisig D.T., Bittner C.B., Zeisig B.B., Garcia-Cuellar M.P., Hess J.L., and Slany R.K. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene 24 (2005) 5525-5532
58. Zhang W., Xia X., Reisenauer M.R., Hemenway C.S., and Kone B.C. Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner. J. Biol. Chem. 281 (2006) 18059-18068